Memorial Sloan Kettering Cancer Center

Supporter

Dedicated to excellence in caring for patients through treatment, research and education

Membership discount for your BMC & SpringerOpen article processing charges (APCs)

As an affiliated author, a membership discount is available on your APC.

Please follow the submission guidelines to benefit from this membership discount.

View the submission guidelines

Memorial Sloan Kettering Cancer Center's Articles

Memorial Sloan Kettering Cancer Center's articles RSS

Page 7 of 36

IDEAL-IQ in an oncologic population: meeting the challenge of concomitant liver fat and liver iron

Authors: Sarah Eskreis-Winkler, Giuseppe Corrias, Serena Monti, Junting Zheng, Marinela Capanu, Simone Krebs, Maggie Fung, Scott Reeder and Lorenzo Mannelli

Citation: Cancer Imaging 2018 18:51

Content type: Research article

Published on: 12 December 2018
CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

Authors: Jennifer D. Brooks, Elizabeth A. Comen, Anne S. Reiner, Irene Orlow, Siok F. Leong, Xiaolin Liang, Lene Mellemkjær, Julia A. Knight, Charles F. Lynch, Esther M. John, Leslie Bernstein, Meghan Woods, David R. Doody, Kathleen E. Malone and Jonine L. Bernstein

Citation: Breast Cancer Research 2018 20:149

Content type: Research article

Published on: 10 December 2018
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance

Authors: Michael M. Boyiadzis, Madhav V. Dhodapkar, Renier J. Brentjens, James N. Kochenderfer, Sattva S. Neelapu, Marcela V. Maus, David L. Porter, David G. Maloney, Stephan A. Grupp, Crystal L. Mackall, Carl H. June and Michael R. Bishop

Citation: Journal for ImmunoTherapy of Cancer 2018 6:137

Content type: Review

Published on: 4 December 2018
The ins and outs of telomere crisis in cancer

Authors: Patrick von Morgen and John Maciejowski

Citation: Genome Medicine 2018 10:89

Content type: Comment

Published on: 27 November 2018
Acquired resistance to immunotherapy in MMR-D pancreatic cancer

Authors: Zishuo Ian Hu, Matthew D. Hellmann, Jedd D. Wolchok, Monika Vyas, Jinru Shia, Zsofia K. Stadler, Luis A. Diaz Jr and Eileen M. O’Reilly

Citation: Journal for ImmunoTherapy of Cancer 2018 6:127

Content type: Case report

Published on: 20 November 2018
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial

Authors: Matthew J. Reilley, Patricia McCoon, Carl Cook, Paul Lyne, Razelle Kurzrock, Youngsoo Kim, Richard Woessner, Anas Younes, John Nemunaitis, Nathan Fowler, Michael Curran, Qinying Liu, Tianyuan Zhou, Joanna Schmidt, Minji Jo, Samantha J. Lee…

Citation: Journal for ImmunoTherapy of Cancer 2018 6:119

Content type: Research article

Published on: 16 November 2018
Exercise inhibits tumor growth and central carbon metabolism in patient-derived xenograft models of colorectal cancer

Authors: Min Lu, Sydney M Sanderson, Amelia Zessin, Kathleen A Ashcraft, Lee W Jones, Mark W Dewhirst, Jason W Locasale and David S Hsu

Citation: Cancer & Metabolism 2018 6:14

Content type: Research

Published on: 15 November 2018
Structure-based assessment and network analysis of targeting 14-3-3 proteins in prostate cancer

Authors: Alex Root, Azadeh Beizaei and H. Alexander Ebhardt

Citation: Molecular Cancer 2018 17:156

Content type: Letter to the Editor

Published on: 31 October 2018
Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease

Authors: Urmi Sengupta, Mauro Montalbano, Salome McAllen, Gerard Minuesa, Michael Kharas and Rakez Kayed

Citation: Acta Neuropathologica Communications 2018 6:113

Content type: Research

Published on: 26 October 2018
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

Authors: Asim Amin, Elizabeth R Plimack, Marc S Ernstoff, Lionel D Lewis, Todd M Bauer, David F McDermott, Michael Carducci, Christian Kollmannsberger, Brian I Rini, Daniel Y C Heng, Jennifer Knox, Martin H Voss, Jennifer Spratlin, Elmer Berghorn, Lingfeng Yang and Hans J Hammers

Citation: Journal for ImmunoTherapy of Cancer 2018 6:109

Content type: Research article

Published on: 22 October 2018

The Correction to this article has been published in Journal for ImmunoTherapy of Cancer 2019 7:73
Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC

Authors: Florent Malard, Myriam Labopin, Christina Cho, Didier Blaise, Esperanza B. Papadopoulos, Jakob Passweg, Richard O’Reilly, Edouard Forcade, Molly Maloy, Liisa Volin, Hugo Castro-Malaspina, Yosr Hicheri, Ann A. Jakubowski, Corentin Orvain, Sergio Giralt, Mohamad Mohty…

Citation: Journal of Hematology & Oncology 2018 11:127

Content type: Research

Published on: 20 October 2018
KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphoma

Authors: Sarah M. Choi, Aleodor A. Andea, Min Wang, Amir Behdad, Lina Shao, Yanming Zhang, Xinyan Lu, David Dittmann, Juan Castro, Yi-Hua Chen and Juehua Gao

Citation: Diagnostic Pathology 2018 13:78

Content type: Case Report

Published on: 15 October 2018
Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy

Authors: Michael Lattanzi, Fang-Ming Deng, Luis A. Chiriboga, Alisa N. Femia, Shane A. Meehan, Gopa Iyer, Martin H. Voss, Yuliya Sundatova, William C. Huang and Arjun V. Balar

Citation: Journal for ImmunoTherapy of Cancer 2018 6:97

Content type: Case report

Published on: 1 October 2018
Reduction in low-dose to normal tissue with the addition of deep inspiration breath hold (DIBH) to volumetric modulated arc therapy (VMAT) in breast cancer patients with implant reconstruction receiving regional nodal irradiation

Authors: Vishruta A. Dumane, Kitwadee Saksornchai, Ying Zhou, Linda Hong, Simon Powell and Alice Y. Ho

Citation: Radiation Oncology 2018 13:187

Content type: Research

Published on: 24 September 2018
Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States

Authors: Eytan M. Stein, Min Yang, Annie Guerin, Wei Gao, Philip Galebach, Cheryl Q. Xiang, Subrata Bhattacharyya, Gaetano Bonifacio and George J. Joseph

Citation: Health and Quality of Life Outcomes 2018 16:193

Content type: Research

Published on: 21 September 2018
Adaptation of Coping Together - a self-directed coping skills intervention for patients and caregivers in an outpatient hematopoietic stem cell transplantation setting: a study protocol

Authors: Tammy Son, Sylvie Lambert, Ann Jakubowski, Barbara DiCicco-Bloom and Carmen G. Loiselle

Citation: BMC Health Services Research 2018 18:669

Content type: Study protocol

Published on: 29 August 2018
Increased epigenetic age in normal breast tissue from luminal breast cancer patients

Authors: Erin W. Hofstatter, Steve Horvath, Disha Dalela, Piyush Gupta, Anees B. Chagpar, Vikram B. Wali, Veerle Bossuyt, Anna Maria Storniolo, Christos Hatzis, Gauri Patwardhan, Marie-Kristin Von Wahlde, Meghan Butler, Lianne Epstein, Karen Stavris, Tracy Sturrock, Alexander Au…

Citation: Clinical Epigenetics 2018 10:112

Content type: Research

Published on: 29 August 2018
Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease

Authors: Piotr Lewczuk, Amélie Gaignaux, Olga Kofanova, Natalia Ermann, Fay Betsou, Sebastian Brandner, Barbara Mroczko, Kaj Blennow, Dominik Strapagiel, Silvia Paciotti, Jonathan Vogelgsang, Michael H. Roehrl, Sandra Mendoza, Johannes Kornhuber and Charlotte Teunissen

Citation: Alzheimer's Research & Therapy 2018 10:87

Content type: Research

Published on: 28 August 2018
Design considerations for early-phase clinical trials of immune-oncology agents

Authors: Nolan A. Wages, Cody Chiuzan and Katherine S. Panageas

Citation: Journal for ImmunoTherapy of Cancer 2018 6:81

Content type: Clinical trials monitor

Published on: 22 August 2018
MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma

Authors: Irene Ferrer, Álvaro Quintanal-Villalonga, Sonia Molina-Pinelo, Jose Manuel Garcia-Heredia, Marco Perez, Rocío Suárez, Santiago Ponce-Aix, Luis Paz-Ares and Amancio Carnero

Citation: Journal of Experimental & Clinical Cancer Research 2018 37:195

Content type: Research

Published on: 17 August 2018

You are viewing the site in preview mode

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center's Articles

IDEAL-IQ in an oncologic population: meeting the challenge of concomitant liver fat and liver iron

CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance

The ins and outs of telomere crisis in cancer

Acquired resistance to immunotherapy in MMR-D pancreatic cancer

STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial

Exercise inhibits tumor growth and central carbon metabolism in patient-derived xenograft models of colorectal cancer

Structure-based assessment and network analysis of targeting 14-3-3 proteins in prostate cancer

Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease

Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC

KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphoma

Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy

Reduction in low-dose to normal tissue with the addition of deep inspiration breath hold (DIBH) to volumetric modulated arc therapy (VMAT) in breast cancer patients with implant reconstruction receiving regional nodal irradiation

Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States

Adaptation of Coping Together - a self-directed coping skills intervention for patients and caregivers in an outpatient hematopoietic stem cell transplantation setting: a study protocol

Increased epigenetic age in normal breast tissue from luminal breast cancer patients

Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease

Design considerations for early-phase clinical trials of immune-oncology agents

MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma